Evaluation of Sickle Cell Liver Disease

CompletedOBSERVATIONAL
Enrollment

42

Participants

Timeline

Start Date

October 16, 2013

Primary Completion Date

June 11, 2019

Study Completion Date

June 11, 2019

Conditions
Sickle Cell Disease
Trial Locations (1)

20892

National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda

All Listed Sponsors
lead

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

NCT01950429 - Evaluation of Sickle Cell Liver Disease | Biotech Hunter | Biotech Hunter